FAAH and migraine disorder: In particular, both brain permeant (e.g., URB597) and impermeant (e.g., URB937) inhibitors of FAAH produce similar pharmacological effects in animal models of migraine on nociceptive tests, including the tail flick test as well as the orofacial and plantar formalin test [8].